• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 3
  3. Author

Online ISSN: 2515-8260

Volume9, Issue3

Assessment of usefulness of AFP as a tumor marker in cases of HCC

    A SATYA SAI VENKATA LAKSHMI D RAGASRI MEGHANA Dr Zaid Munir Amro Musa Mohamed Elamin Alam Alhouda ALI ABDALLA ALI OSMAN Juan Carlos Batlle Nargis Tabasom Mateen Dr.Ayush Neupane

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 3, Pages 1835-1839

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background:Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related
death worldwide. The present study was conducted to assess usefulness of AFP as a tumor
marker in cases of HCC.
Materials & Methods:72 hepatocellular carcinoma patients of both genders were enrolled. 5
ml of venous blood was taken and level of AFP was measured.
Results: Out of 72, males were 42 and females were 30. There were 30 HBV, 12 HCV, 10
HBV and HCV positive, 7 HBV and HCV negative, 5 AFB1 positive and 8 HBV and AFB1
positive. AFP positivity was seen in 18, 3, 8, 2, 3 and 4 respectively. The mean AFP titre
level (ng/ml) was 504.2, 482.6, 572.4, 461.2, 476.2 and 224.7 respectively. The difference
was significant (P< 0.05).
Keywords:
    cancer hepatocellular carcinoma tumour
  • PDF (160 K)
  • XML
(2022). Assessment of usefulness of AFP as a tumor marker in cases of HCC. European Journal of Molecular & Clinical Medicine, 9(3), 1835-1839.
A SATYA SAI VENKATA LAKSHMI D RAGASRI MEGHANA Dr Zaid Munir Amro Musa Mohamed Elamin Alam Alhouda ALI ABDALLA ALI OSMAN Juan Carlos Batlle Nargis Tabasom Mateen Dr.Ayush Neupane. "Assessment of usefulness of AFP as a tumor marker in cases of HCC". European Journal of Molecular & Clinical Medicine, 9, 3, 2022, 1835-1839.
(2022). 'Assessment of usefulness of AFP as a tumor marker in cases of HCC', European Journal of Molecular & Clinical Medicine, 9(3), pp. 1835-1839.
Assessment of usefulness of AFP as a tumor marker in cases of HCC. European Journal of Molecular & Clinical Medicine, 2022; 9(3): 1835-1839.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 83
  • PDF Download: 85
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus